Antibiotice S.A. (BVB:ATB)
Romania
· Delayed Price · Currency is RON 2.400
-0.030 (-1.23%)
At close: Mar 3, 2025
Antibiotice Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 686.13 | 614.16 | 497.5 | 376.76 | 346.78 | Upgrade
|
| Other Revenue | 2.77 | 1.12 | 7.5 | 2.07 | 0.45 | Upgrade
|
| Revenue | 688.9 | 615.29 | 505 | 378.83 | 347.22 | Upgrade
|
| Revenue Growth (YoY) | 11.96% | 21.84% | 33.31% | 9.10% | -12.13% | Upgrade
|
| Cost of Revenue | 234.11 | 230.09 | 187.45 | 146.97 | 109.56 | Upgrade
|
| Gross Profit | 454.79 | 385.19 | 317.55 | 231.86 | 237.66 | Upgrade
|
| Selling, General & Admin | 1,951 | 161.69 | 130.53 | 125.92 | 118.01 | Upgrade
|
| Other Operating Expenses | 123.38 | 98.2 | 91.94 | 47.57 | 60.43 | Upgrade
|
| Operating Expenses | 2,119 | 287.77 | 244.73 | 197.61 | 200.24 | Upgrade
|
| Operating Income | -1,665 | 97.42 | 72.81 | 34.25 | 37.42 | Upgrade
|
| Interest Expense | -4.54 | -4.15 | -3.59 | -3.52 | -4.93 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.26 | -0.95 | -0.8 | -0.22 | -3.72 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,772 | 0.08 | -0.18 | -0.21 | -0.44 | Upgrade
|
| EBT Excluding Unusual Items | 103.29 | 92.42 | 68.25 | 30.3 | 28.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0 | 0.1 | - | - | Upgrade
|
| Asset Writedown | - | -0.9 | -3.04 | - | - | Upgrade
|
| Pretax Income | 103.29 | 91.52 | 65.31 | 30.3 | 28.33 | Upgrade
|
| Income Tax Expense | 3.88 | 10.44 | 13.84 | 0.36 | 1.94 | Upgrade
|
| Net Income | 99.42 | 81.09 | 51.47 | 29.94 | 26.39 | Upgrade
|
| Net Income to Common | 99.42 | 81.09 | 51.47 | 29.94 | 26.39 | Upgrade
|
| Net Income Growth | 22.60% | 57.54% | 71.92% | 13.46% | -14.39% | Upgrade
|
| Shares Outstanding (Basic) | 671 | 671 | 671 | 671 | 671 | Upgrade
|
| Shares Outstanding (Diluted) | 671 | 671 | 671 | 671 | 671 | Upgrade
|
| EPS (Basic) | 0.15 | 0.12 | 0.08 | 0.04 | 0.04 | Upgrade
|
| EPS (Diluted) | 0.15 | 0.12 | 0.08 | 0.04 | 0.04 | Upgrade
|
| EPS Growth | 22.61% | 57.54% | 71.92% | 13.46% | -14.39% | Upgrade
|
| Free Cash Flow | - | 39.43 | 78.09 | 15.39 | 46.06 | Upgrade
|
| Free Cash Flow Per Share | - | 0.06 | 0.12 | 0.02 | 0.07 | Upgrade
|
| Dividend Per Share | - | 0.083 | 0.008 | 0.003 | 0.003 | Upgrade
|
| Dividend Growth | - | 946.74% | 147.72% | -3.27% | -88.94% | Upgrade
|
| Gross Margin | 66.02% | 62.60% | 62.88% | 61.20% | 68.45% | Upgrade
|
| Operating Margin | -241.64% | 15.83% | 14.42% | 9.04% | 10.78% | Upgrade
|
| Profit Margin | 14.43% | 13.18% | 10.19% | 7.90% | 7.60% | Upgrade
|
| Free Cash Flow Margin | - | 6.41% | 15.46% | 4.06% | 13.27% | Upgrade
|
| EBITDA | -1,621 | 125.35 | 95.38 | 58.68 | 59.52 | Upgrade
|
| EBITDA Margin | -235.24% | 20.37% | 18.89% | 15.49% | 17.14% | Upgrade
|
| D&A For EBITDA | 44.06 | 27.93 | 22.57 | 24.43 | 22.1 | Upgrade
|
| EBIT | -1,665 | 97.42 | 72.81 | 34.25 | 37.42 | Upgrade
|
| EBIT Margin | -241.64% | 15.83% | 14.42% | 9.04% | 10.78% | Upgrade
|
| Effective Tax Rate | 3.75% | 11.40% | 21.19% | 1.20% | 6.85% | Upgrade
|
| Advertising Expenses | - | - | - | 11.01 | 8.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.